Liver metastases and the efficacy of the PD-1 or PD-L1 inhibitors in cancer: a meta-analysis of randomized controlled trials

Liver metastases and the efficacy of the PD-1 or PD-L1 inhibitors in cancer: a meta-analysis of randomized controlled trials

Objective: To explore the relations between liver metastases (LM) and the efficacy of the treatments with programmed cell death 1 (PD-1) or programmed cell death ligand 1 (PD-L1) inhibitors. Method: Pubmed, Embase, American Society of Clinical Oncology and the European Society for Medical Oncology w...

Full description

Bibliographic Details
Main Authors: Shan Li, Shanquan Sun, Hui Xiang, Jing Yang, Minyong Peng, Qing Gao
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
liver metastases
pd-1 inhibitors
pd-l1 inhibitors
overall survival
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1746113

Internet

http://dx.doi.org/10.1080/2162402X.2020.1746113

Similar Items